DISCOUNT ZERTIFIKAT - AMGEN | Market Closed - Börse Stuttgart 11:57:22 2024-05-17 EDT | ||
| 207.8 EUR | +0.02% |
|
| Current month | +0.20% | ||
| 1 month | +1.13% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-17 | 207.8 | +0.02% |
| 24-05-16 | 207.8 | +0.13% |
| 24-05-15 | 207.5 | -0.35% |
| 24-05-14 | 208.2 | -0.26% |
| 24-05-13 | 208.8 | -0.08% |
Delayed Quote Börse Stuttgart
Last update May 17, 2024 at 11:57 am
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME680N |
| ISIN | DE000ME680N3 |
| Date issued | 2024-01-02 |
| Maturity | 2024-09-20 (125 Days) |
| Parity | 1 : 1 |
| Emission price | 200 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 209.3 € |
|---|---|
| Lowest since issue | 196.9 € |
| Spread | 0.05 € |
| Spread % | 0.02% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5
USD
Average target price
314.1
USD
Spread / Average Target
+0.51%
- Stock Market
- Certificates
- Certificat
